Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
- PMID: 1310894
- DOI: 10.1016/0092-8674(92)90180-k
Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
Abstract
In man, Hodgkin's disease (HD) represents the most frequent lymphoma entity whose pathogenesis is still unknown. In order to contribute to the characterization of the molecular mechanisms of this disease, cDNAs coding for the HD characteristic antigen CD30 were cloned from expression libraries of the human HUT-102 cell line using the monoclonal antibodies Ki-1 and Ber-H2. The open reading frame of the cDNA that can be translated from two mRNA species of 2.6 kb, and 3.8 kb, respectively, predicts a 595 amino acid protein with leader, extracellular, single transmembrane, and intracellular domains. When expressed in COS-1 cells, the cDNA presented properties comparable to native CD30 antigen. The CD30 extracellular domain proved to be homologous to members of the nerve growth factor receptor superfamily. Six cysteine-rich motifs could be recognized within the putative ligand-binding domain.
Similar articles
-
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.Cell. 1993 Jul 2;73(7):1349-60. doi: 10.1016/0092-8674(93)90361-s. Cell. 1993. PMID: 8391931
-
Cloning and expression of murine CD27: comparison with 4-1BB, another lymphocyte-specific member of the nerve growth factor receptor family.Eur J Immunol. 1993 Apr;23(4):943-50. doi: 10.1002/eji.1830230427. Eur J Immunol. 1993. PMID: 8384562
-
CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.Leuk Lymphoma. 1996 Feb;20(5-6):397-409. doi: 10.3109/10428199609052421. Leuk Lymphoma. 1996. PMID: 8833395 Review.
-
Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.J Biol Chem. 1992 May 25;267(15):10709-15. J Biol Chem. 1992. PMID: 1375228
-
Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.Leuk Lymphoma. 2000 Jul;38(3-4):317-26. doi: 10.3109/10428190009087022. Leuk Lymphoma. 2000. PMID: 10830738 Review.
Cited by
-
Standardization of CD30 immunohistochemistry staining among three automated immunostaining platforms.Pathol Int. 2024 Sep;74(9):530-537. doi: 10.1111/pin.13472. Epub 2024 Aug 22. Pathol Int. 2024. PMID: 39171823 Free PMC article.
-
Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies.MedComm (2020). 2024 Jul 28;5(8):e671. doi: 10.1002/mco2.671. eCollection 2024 Aug. MedComm (2020). 2024. PMID: 39070179 Free PMC article. Review.
-
Novel OX40 and 4-1BB derived spacers enhance CD30 CAR activity and safety in CD30 positive lymphoma models.Mol Ther. 2024 Oct 2;32(10):3504-3521. doi: 10.1016/j.ymthe.2024.06.037. Epub 2024 Jun 29. Mol Ther. 2024. PMID: 38946142
-
Advances in CAR-T-cell therapy in T-cell malignancies.J Hematol Oncol. 2024 Jun 24;17(1):49. doi: 10.1186/s13045-024-01568-z. J Hematol Oncol. 2024. PMID: 38915099 Free PMC article. Review.
-
Mechanism of action and therapeutic targeting of CD30 molecule in lymphomas.Front Oncol. 2023 Dec 22;13:1301437. doi: 10.3389/fonc.2023.1301437. eCollection 2023. Front Oncol. 2023. PMID: 38188299 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
